Dartmouth's Geisel School of Medicine and Aeras, a global nonprofit biotech, announced a collaboration to jointly conduct a trial of a new vaccine against tuberculosis (TB), one of the world's deadliest diseases. The vaccine, ...
Mar 19, 2014
0
0
Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately ...
Feb 5, 2014
0
0
In Africa, issues of vaccine supply, financing, and sustainability require urgent attention if the Millennium Development Goals are to be achieved, according to African experts writing in this week's PLOS Medicine.
Mar 19, 2013
0
0
HIV-1 is a genetically diverse collection of viruses, making it a moving target in vaccine development.
Nov 12, 2012
0
1
After the SARS-CoV (severe acute respiratory syndrome coronavirus) outbreak in 2003, academia experts in immunology and molecular biology joined forces with industrial vaccine production experts in order to develop preventive ...
Aug 28, 2012
0
0
Today, the Sabin Vaccine Institute, in partnership with the George Washington University and the Children's National Medical Center, began vaccinating participants for a Phase 1 clinical trial of a novel human hookworm vaccine. ...
Jun 13, 2012
0
0
Rotavirus vaccines offer the best hope for preventing severe rotavirus disease and the deadly dehydrating diarrhea that it causes, particularly in low-resource settings where treatment for rotavirus infection is limited or ...
Apr 24, 2012
0
0
Canada should show leadership in supporting adoption of the rotavirus vaccination in developing countries, but it must also ensure that all Canadian infants are vaccinated against the virus, states an editorial in CMAJ (Canadian ...
Apr 10, 2012
0
0
Vaccines against the primary cause of deaths from pneumonia in developing countries could save millions of lives and are highly cost-effective, according to a comprehensive new analysis to be released on Thursday, Nov. 10.
Nov 10, 2011
0
0
